Adoptive T cell therapy of cancer
- 30 April 2009
- journal article
- editorial
- Published by Elsevier BV in Current Opinion in Immunology
- Vol. 21 (2), 187-189
- https://doi.org/10.1016/j.coi.2009.03.006
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Antigen choice in adoptive T-cell therapy of cancerCurrent Opinion in Immunology, 2009
- The promise and potential pitfalls of chimeric antigen receptorsCurrent Opinion in Immunology, 2009
- Adoptive immunotherapy of cancer using CD4+ T cellsCurrent Opinion in Immunology, 2009
- Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1New England Journal of Medicine, 2008
- Treatment of Metastatic Renal Cell Carcinoma With Autologous T-Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX: First Clinical ExperienceJournal of Clinical Oncology, 2006
- Adoptive immunotherapy for cancer: building on successNature Reviews Immunology, 2006
- Sporadic immunogenic tumours avoid destruction by inducing T-cell toleranceNature, 2005
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- T-cell-receptor gene therapyNature Reviews Immunology, 2002
- Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors.Proceedings of the National Academy of Sciences of the United States of America, 1993